Global Hidradenitis Suppurativa Market Size and Forecast 2023-2032|Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company,

The Hidradenitis Suppurativa Global Market Report 2023, provides comprehensive information on the hidradenitis suppurativa market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Hidradenitis Suppurativa Market’s Growth:

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

The global hidradenitis suppurativa market is expected to grow from $0.98 billion in 2022 to $1.06 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The hidradenitis suppurativa market is expected to reach $1.4 billion in 2027 at a CAGR of 7.2%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12599&type=smp

Utilization of biologics is a key trend gaining popularity in the hidradenitis suppurativa market. Major companies operating in the hidradenitis suppurativa market are investing in research and development, resulting in an approved biologic therapy for hidradenitis suppurativa and sustaining their position in the market. For instance, in June 2023, the European regulatory authority approved Novartis AG, a Switzerland-based pharmaceutical company, for Cosentyx for hidradenitis suppurativa. Cosentyx is the first and only completely human biologic that specifically blocks interleukin-17A, an essential cytokine associated with hidradenitis suppurative disease. Cosentyx is a well-established medication that has been clinically researched for over 14 years.

The hidradenitis suppurativa market is segmented:

1) By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne

2) By Product: Tablet, Intravenous (IV) Injection

3) By Route Of Administration: Oral, Parenteral

4) By Treatment: Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments

5) By End User: Hospital, Specialty Clinic, Homecare, Other End Users

North America was the largest region in the hidradenitis suppurativa market in 2022.

The table of contents in TBRC’s hidradenitis suppurativa market report includes:

1. Executive Summary

2. Hidradenitis Suppurativa Market Characteristics

3. Hidradenitis Suppurativa Market Trends And Strategies

4. Hidradenitis Suppurativa Market – Macro Economic Scenario

5. Global Hidradenitis Suppurativa Market Size and Growth

.

.

.

26. South America Hidradenitis Suppurativa Market

27. Brazil Hidradenitis Suppurativa Market

28. Middle East Hidradenitis Suppurativa Market

29. Africa Hidradenitis Suppurativa Market

30. Hidradenitis Suppurativa Market Competitive Landscape And Company Profiles

Top Major Players:

• Pfizer Inc
• Johnson & Johnson
• AbbVie Inc
• Novartis AG
• Bristol-Myers Squibb Company

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model